Punarnavadi Guggulu

Punarnavadi Guggulu is a classical Ayurvedic guggulu, a resin-based preparation. Listed in Ayurvedic Formulary of India (AFI) Part I; Punarnava (Boerhavia diffusa) individually monographed in Ayurvedic Pharmacopoeia of India (API) Part I; recognized by CCRAS for Shotha (edema) management.

Key facts
Also known as	Punarnavadi Guggulu, PunarnavadiGuggulu
Pharmacopoeia status	Listed in Ayurvedic Formulary of India (AFI) Part I; Punarnava (Boerhavia diffusa) individually monographed in Ayurvedic Pharmacopoeia of India (API) Part I; recognized by CCRAS for Shotha (edema) management

Names and identification

Language	Name
English	Punarnavadi Guggulu

Key Ingredients

Punarnava (Boerhavia diffusa)
Shuddha Guggulu|Shuddha Guggulu (Commiphora wightii)
Triphala - Haritaki (Terminalia chebula), Bibhitaki (Terminalia bellirica), Amalaki (Emblica officinalis)
Trikatu - Shunthi (Zingiber officinale), Maricha (Piper nigrum), Pippali (Piper longum)
Eranda Taila (Castor oil - Ricinus communis)
Trivrit (Operculina turpethum)
Danti (Baliospermum montanum)

Where is it described in the classical texts?

Sharangdhara Samhita (Madhyama Khanda, Chapter 7); also referenced in Bhaishajya Ratnavali (Shotha/Mutrakrichra Chikitsa) and Yoga Ratnakara

How does it work?

Diuretic and anti-edema action: Punarnava (Boerhavia diffusa) contains punarnavine and rotenoids that promote diuresis and reduce edema without disturbing electrolyte balance
Anti-inflammatory NF-kB modulation: Guggulsterones interfere with NF-kB, a key inflammation mediator, reducing inflammatory pathways in kidneys and joints
Renoprotective action: Punarnava improves glomerular filtration rate, reduces serum creatinine and blood urea nitrogen, and decreases albuminuria through nephroprotective mechanisms
Hepatoprotective synergy: Combined Punarnava and Triphala protect hepatocytes from oxidative damage, supporting liver-kidney detoxification axis

Which traditional uses are supported by research?

Chronic renal failure management validated in clinical study of 100 patients showing significant reduction in creatinine (20.71%), blood urea (36.15%), and edema (71.56%)
Edema (Shotha) reduction validated through demonstrated diuretic properties without electrolyte imbalance
Kidney function improvement validated through enhanced filtration capacity and reduced proteinuria in clinical studies
Gout (Vatarakta) management validated when combined with Kaishore Guggulu in clinical case series

What do recent clinical trials show?

Patel MV, Gupta SN, Patel NG 2011. Effects of Ayurvedic treatment on 100 patients of chronic renal failure (other than diabetic nephropathy). Ayu. PMID 22661841 · doi:10.4103/0974-8520.96120
Study of 100 CRF patients showed serum creatinine reduced by 20.71%, blood urea reduced by 36.15%, albuminuria reduced by 36.70%, hemoglobin increased by 4.65%, and edema reduced by 71.56%.
Prashanth GS, Baghel MS, Ravishankar B and others 2010. A clinical comparative study of the management of chronic renal failure with Punarnavadi compound. Ayu. PMID 22131708 · doi:10.4103/0974-8520.72388
Small study (N=30) found reduced ankle swelling within three weeks, improved kidney filtration capacity, and cleansed urinary tract with healthy urine output support.

1 further claim previously listed here could not be traced to a published paper and has been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.

Recent safety updates

Generally safe at recommended doses; may cause loose stools due to castor oil component; patients with severe kidney disease should use under strict medical supervision with regular monitoring of kidney function
Avoid in pregnancy and lactation; may interact with diuretic medications and antihypertensives; discontinue if allergic reaction occurs; not recommended for children without physician guidance

What is it made of?

Key Active Markers

Derived from constituent herbs (see individual herb profiles)
Standardized on primary bioactive markers

Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

Dosage forms and preparation

Dosage Forms: Vati (pill/tablet), Capsule

Standard Dosage: 2 tablets twice daily

Bioavailability: Guggulu resin acts as natural bioenhancer; guggulsterones have moderate oral bioavailability (~40%); lipophilic matrix aids absorption of co-formulated herbs

Optimal Timing: After meals, twice daily

Shelf Life: 2 years (guggulu preparations per ASU); potency may decrease after 1 year

Storage: Airtight container, cool dry place; guggulu preparations are hygroscopic

Marker Compounds: Guggulsterone, Punarnavine, Boeravinone

Quality Parameters: Weight variation ±5%, disintegration <60 min, hardness 4-8 kP, assay: Guggulsterone, Punarnavine, Boeravinone, guggulsterone content

Vehicle (Anupana): Warm water

Synergistic Combinations

Key herbs: Punarnava, Guggulu, Triphala, Trikatu; guggulu potentiates anti-inflammatory and hypolipidemic actions

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.